Ray Dalio acquired 24.6 Thousand Neogenomics shares worth $337 Thousand. That's 0.00% of their equity portfolio (631st largest holding). The first Neogenomics trade was made in Q1 2023. Since then Ray Dalio bought shares one more times and sold shares on three occasions. The investor's estimated purchase price is $353 Thousand, resulting in a loss of 4.3%.